Nose spray during labor may slash postpartum depression risk
NCT ID NCT07501728
First seen Apr 17, 2026 · Last updated May 02, 2026 · Updated 2 times
Summary
This study tests whether a single dose of a nose spray (dexmedetomidine) given before labor pain relief can reduce the chance of postpartum depression (PPD) in women having a vaginal delivery. About 270 women will be randomly assigned to receive either the active spray or a placebo. The main goal is to see if fewer women develop PPD 42 days after giving birth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION (PPD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chengdu Jinjiang District Women & Children Health Hospital,
Chengdu, Sichuan, 610011, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.